PCK

3.57%

2.9¢ painchek ltd

PainChek General Discussion, page-2537

First 2537 Last

Share
Profile

Follow
zmans

14,475 Posts.

1403

28/05/19

18:57

Post #: 38787710
Share

Originally posted by Hedg: ↑

How worries change from week to week.....

Yes, of course one should be prudent about hasty expansion into foreign markets. But I feel management is very competent, and will find good partners in key leading markets.

With what must be one of the best spent $5 million of tax-money recently made by any Government in the world, PCK set to leap the adoption chasm in Australia and reach out to key global markets.

IT is a very fast moving market. The golden moment for PCK is now.

It is in the nature of the product that PCK can scale and expand globally very quickly. The tech is sound, and it's use can be scaled up infinitely to meet demand.

The important thing in cyberspace is to get in first, make your product the brand leader, and hold that position.

Look how Facebook is close to unassailable - no matter how more superior subsequent offerings may have been.

I rate the value of PCK to humanity far above that of Fakebook. On this trajectory now, PCK will be the global standard. It will be the dominant brand. PCK will demonstrate breathtaking economies of scale and develop networks of users that newcomers will find close to unassailable.

I would not fret about Argentina, in or not, at the moment. The market that will set the pace in that Hemisphere is the English speaking USA. It's a dynamic market that will pick up on Australian success very quickly.

UK is now poised to be the leader in Europe; Germany, France, Scandinavia, and the rest will be along soon enough.

In Asia, Singapore, Japan, and others, are eager adopters of technology. What happens to our IP in China, who knows? But the rest of the world is enough.

Health systems and regulatory issues vary across the globe, but the major markets like USA generally set the pace. With clear benefits others will be eager to adopt.

In a few years time, we may indeed have PCK available in 17 different Eskimo tongues - and it may be available on line in Somalia, the Cook Islands and Bhutan - all of which is a wonderful conclusion - but not the priority just now.

Roll out through the global leading and influencing markets - most of which already widely use English in IT and medicine.

Hello world.......

Expand

Top post H, totally agree. Baby steps has been the company’s motto to date by making sure they have the right partnerships in place. Would love to know why PD is flying to the UK end of this week. I guess more will be revealed on his return esp with FDA progress and possible further roll outs in the UK. Our current partner LeeCare have a strong foothold in the UK as well so possible partnership with them could be on the cards.

PCK Price at posting: 14.0¢ Sentiment: None Disclosure: Held
12 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 17,876 more messages in this thread...

First 2537 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 2.9¢		Change 0.001(3.57%)		Mkt cap ! $47.43M

Open	High	Low	Value	Volume
2.8¢	2.9¢	2.8¢	$4.805K	170.1K

Buyers (Bids)

No.	Vol.	Price($)
1	137602	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	62153	1

View Market Depth

No.	Vol.	Price($)
1	137602	0.028
5	525740	0.027
2	90000	0.026
3	243154	0.025
3	120000	0.024

Price($)	Vol.	No.
0.029	62153	1
0.030	117884	1
0.032	226144	3
0.033	691416	4
0.034	5874	1

Last trade - 16.10pm 31/05/2024 (20 minute delay)


Last 2.9¢		Change 0.001 ( 0.00 %)
Open	High	Low	Volume
2.8¢	3.0¢	2.8¢	72529
Last updated 15.59pm 31/05/2024 ?

PCK (ASX) Chart

PainChek General Discussion, page-2537

Featured News

Telix testing shows efficacy of anti-prostate cancer therapy

Peak shale oil and fracking activity drives demand for Eden's Optiblend in the USA

Daily ASX Market Close: Late run sees market lift 1%, May 31, 2024

Thor reports 200% increase in tungsten at NT's Molyhil

The $ and the sense: Andrew Demetriou talks through sports deals that shaped AFL

Talga shows expansion options for Sweden's Vittangi graphite project

Little Green Pharma's cannabis sales leap 30%

Spacetalk makes European Market Reentry with Elisa

Making the best of an inflationary environment

Daily ASX Market Update: Health pushes shares into gain terrain - May 31, 2024

Buyers (Bids)

Sellers (Offers)

Featured News

PainChek General Discussion, page-2537

Featured News

Top Stories

Telix testing shows efficacy of anti-prostate cancer therapy

Peak shale oil and fracking activity drives demand for Eden's Optiblend in the USA

Daily ASX Market Close: Late run sees market lift 1%, May 31, 2024

Thor reports 200% increase in tungsten at NT's Molyhil

The $ and the sense: Andrew Demetriou talks through sports deals that shaped AFL

Talga shows expansion options for Sweden's Vittangi graphite project

Little Green Pharma's cannabis sales leap 30%

Spacetalk makes European Market Reentry with Elisa

Making the best of an inflationary environment

Daily ASX Market Update: Health pushes shares into gain terrain - May 31, 2024

Buyers (Bids)

Sellers (Offers)

Featured News